PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma

Figure 5

The correlation between PLEKHA4 expression and the clinical characteristics of glioma patients. (a) PLEKHA4 expression levels in glioma (red) and corresponding normal brain tissues (blue) from TCGA datasets. (b–f) Correlation of PLEKHA4 expression with age (b), WHO grade (c), IDH mutation status (d), 1p19q codeletion status (e), and histology type (f).

(a)

(b)

(c)

(d)

(e)

(f)